Get access

Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases

Authors


F. Toledo. E-mail:fernandotoledoalberola@hotmail.com

No abstract is available for this article.

Get access to the full text of this article

Ancillary